Mitsukuni Murasaki: murasaki@i-cnsp.com
Tsukasa Koyama: koyama@ohyachi-hp.or.jp
Shigenobu Kanba: skanba@npsych.med.kyushu-u.ac.jp
Masahiro Takeuchi: takeuchim@pharm.kitasato-u.ac.jp
Yuriko Shimizu: yuriko.shimizu@astellas.com
Eri Arita: eri.arita@astellas.com
Kentaro Kuroishi: kentarou.kuroishi@astellas.com
Masahiro Takeuchi: masahiro-takeuchi@astellas.com
Shinya Kamei: +81-3-3244-2606
,
shinya.kamei@astellas.com
Journal ID (nlm-ta): Psychopharmacology (Berl)
Journal ID (iso-abbrev): Psychopharmacology (Berl.)
Title:
Psychopharmacology
Publisher:
Springer Berlin Heidelberg
(Berlin/Heidelberg
)
ISSN
(Print):
0033-3158
ISSN
(Electronic):
1432-2072
Publication date
(Electronic):
1
August
2018
Publication date PMC-release: 1
August
2018
Publication date
(Print):
2018
Volume: 235
Issue: 10
Pages: 2859-2869
Affiliations
[1
]Institute of CNS Pharmacology, 3-14-20 Sagamiohno, Minami-ku, Sagamihara, Kanagawa
252-0303 Japan
[2
]Ohyachi Hospital, Clinical Research Center, 5-7-10 Ohyachi-higashi, Atsubetsu-ku,
Sapporo, Hokkaido 004-0041 Japan
[3
]ISNI 0000 0001 2242 4849, GRID grid.177174.3, Department of Neuropsychiatry, Graduate School of Medical Sciences, , Kyushu University, ; 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582 Japan
[4
]ISNI 0000 0000 9206 2938, GRID grid.410786.c, Department of Clinical Medicine, School of Pharmacy, , Kitasato University, ; 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8641 Japan
[5
]GRID grid.418042.b, Japan/Asia Clinical Development 2, Astellas Pharma Inc., ; Astellas Pharma Inc.; 2-5-1 Nihonbashi-Honcho, Chuo-ku, Tokyo, 103-8411 Japan
[6
]ISNI 0000 0004 1793 4635, GRID grid.476166.4, Global Clinical Science, Astellas Pharma Europe B.V, ; Sylviusweg 62, PO Box 344, 2300 AH Leiden, The Netherlands
[7
]GRID grid.418042.b, Japan-Asia Data Science, Astellas Pharma Inc., ; 2-5-1 Nihonbashi-Honcho, Chuo-ku, Tokyo, 103-8411 Japan
[8
]ISNI 0000 0004 0507 1326, GRID grid.423286.9, Astellas Pharma Global Development, Inc., ; 1 Astellas Way, Northbrook, IL 60062 USA
Article
Publisher ID:
4977
DOI: 10.1007/s00213-018-4977-6
PMC ID: 6182597
PubMed ID: 30069587
SO-VID: 3c51786e-f140-49d0-8da3-5cd30daf0e96
Copyright © © The Author(s) 2018
License:
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits
unrestricted use, distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
Funded by: FundRef http://dx.doi.org/10.13039/501100002975, Dainippon Sumitomo Pharma;
Funded by: Janssen Phrma (Jp)
Funded by: Nippon Chemiphar
Funded by: FundRef http://dx.doi.org/10.13039/501100004820, Mochida Pharmaceutical Company;
Funded by: FundRef http://dx.doi.org/10.13039/501100003769, Eisai;
Funded by: FundRef http://dx.doi.org/10.13039/100010793, Pfizer Japan;
Funded by: Mitsubishi Tanabe Pharma (Jp)
Funded by: FundRef http://dx.doi.org/10.13039/501100004169, Meiji Seika Pharma;
Funded by: Yoshitomiyakuhin (Jp)
Funded by: FundRef http://dx.doi.org/10.13039/501100005612, Shionogi;
Funded by: FundRef http://dx.doi.org/10.13039/501100004948, Astellas Pharma;